Mabura 40mg Pen

Mabura 40mg Pen contains adalimumab, a TNF inhibitor used in the treatment of rheumatoid arthritis by injection. It is prescribed as monotherapy or in combination with other therapies to reduce joint pain, swelling, and stiffness in autoimmune conditions. Patients with long-term treatment requirements often compare adalimumab injection prices at 40mg strength or evaluate adalimumab biosimilar brands available in India before initiating therapy. This medicine is also effective in improving symptoms of juvenile idiopathic arthritis, enthesitis-related arthritis, and is indicated for ankylosing spondylitis when spinal inflammation is present. Patients frequently review the Mabura 40mg Pen price and consider Mabura 40mg Pen information before selecting this biosimilar. Mabura is also indicated for psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, and non-infectious uveitis. Patients administering this medicine at home typically follow Mabura 40mg subcutaneous injection instructions to ensure safe and correct administration. The Mabura 40mg dosage frequency is typically once every two weeks, as advised by the physician. Individuals seeking online access sometimes search for Mabura 40mg Pen purchase options, particularly through a certified Mabura 40mg Pen wholesaler in India. The product is manufactured by Hetero, an Indian pharmaceutical company. Avoid using this medicine if allergic to its ingredients. It is contraindicated in active tuberculosis, serious infections, or moderate to severe heart failure. Inform your doctor if you have lung, liver, or kidney problems, or ongoing infections. Pregnant women or those planning pregnancy should consult a healthcare professional before starting treatment. The Mabura 40mg Pen indications and adverse effects must be reviewed with a healthcare professional.

Rheumatoid arthritis Polyarticular juvenile idiopathic arthritis Enthesitis-related arthritis Ankylosing spondylitis Axial spondyloarthritis without radiographic evidence of ankylosing spondylitis Psoriatic arthritis Plaque psoriasis Hidradenitis suppurativa Crohn’s disease Ulcerative colitis Non-infectious uveitis

The active ingredient in this medicine is a human monoclonal antibody. Monoclonal antibodies are proteins that attach to a specific target. The target of Mabura 40mg pen is a protein called tumor necrosis factor (TNFα), which is involved in the immune (defense) system and at increased levels in the inflammatory diseases. By attaching to TNFα, Humira decreases inflammation in these diseases.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Injection site reactions Rash Headache Sinusitis Upper respiratory infections Fever Serious Heart problems Abnormal heart beat Severe skin reactions GI bleeding Abnormal blood count values Liver injury Bone problems Infections Severe respiratory problems